ProCE Banner Activity

Treatment Decision Support Tool Enhances Therapy Considerations for Metastatic Clear Cell RCC

Clinical Thought

An expert discusses the nuances of treating metastatic clear cell RCC and how a new treatment decision support tool can help oncologists with informed decision-making.

Released: July 10, 2023

Share

Faculty

Wenxin Xu

Wenxin Xu, MD

Instructor of Medicine
Lank Center for Genitourinary Oncology
Physician
Medical Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AVEO Pharmaceuticals, Inc., Bristol Myers Squibb, and Exelixis, Inc.

AVEO Pharmaceuticals, Inc.

Bristol Myers Squibb

Exelixis, Inc.

Faculty Disclosure

Primary Author

Wenxin Xu, MD

Instructor of Medicine
Lank Center for Genitourinary Oncology
Physician
Medical Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts

Wenxin Xu, MD: consultant/advisor/speaker: Exelixis, Jazz Pharmaceuticals.